Quantcast
Last updated on April 19, 2014 at 13:20 EDT

Latest Immunosuppressive drug Stories

2011-09-23 11:27:41

Immediately after transplantation, patients should minimize or avoid using certain anti-rejection drugs Patients who receive kidney transplants must take lifelong medications that, while preventing organ rejection, can also compromise other aspects of health. Immunosuppresive drugs called calcineurin inhibitors protect transplanted organs from being rejected, but they can be toxic to the kidneys over the long term and can make patients susceptible to infection, cancer, and other threats....

2011-09-21 12:58:22

Researchers at Albert Einstein College of Medicine of Yeshiva University have shown that close supervision by rheumatologists and the use of immunosuppressant drugs improve the survival of lupus patients with end-stage kidney disease–a finding that could reverse long-standing clinical practice. Their study appeared in the September 1 online edition of the Journal of Rheumatology. At least 1.5 million Americans (more than 90 percent of them women) have lupus (officially known as lupus...

2011-09-19 15:03:00

Participants met with Members of Congress to Discuss Extending Immunosuppressive Drug Coverage for Transplant Patients, Deficit Reduction Efforts WASHINGTON, Sept. 19, 2011 /PRNewswire-USNewswire/ -- Last week, patient advocates with Dialysis Patient Citizens (DPC) traveled to Washington, D.C. to meet with their Members of Congress and discuss legislative issues important to the 31 million Americans with chronic kidney disease. Participants from 21 states came to the nation's capital for...

2011-09-13 21:41:29

A new study published in the American Journal of Transplantation reveals that substitution of a brand name immunosuppressive drug with a generic (manufactured by Sandoz) for preventing rejection of transplanted organs appears to be safe for transplant recipients. Tacrolimus is an immunosuppressive drug that is used to prevent rejection of transplanted organs following organ transplantation. In August 2009, another pharmaceutical company received approval from the FDA for a generic...

2011-07-29 14:38:29

Combination of two immunosuppressive drugs led to less organ rejection, better organ health after transplant For the thousands of patients who receive kidney transplants in the United States each year, preventing organ rejection without compromising other aspects of health requires a delicate balance of medications. Immunosuppresive drugs that protect transplanted organs can also cause serious side effects, including compromising patients' immunity to infection, cancer, and other threats....

2011-07-28 07:47:00

PRINCETON, N.J., July 28, 2011 /PRNewswire/ -- Soligenix, Inc. (Soligenix or the Company) (OTC BB: SNGX), a late-stage biopharmaceutical company, announces the expansion and amendment of its North American licensing partnership with Sigma-Tau Pharmaceuticals, Inc. (Sigma-Tau) for the development and commercialization of orBec® (oral beclomethasone dipropionate or Oral BDP) into the European territory. As part of the amended agreement, Sigma-Tau has made a $5 million...

2011-07-25 08:06:00

ATLANTA, July 25, 2011 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today announced that its MassTrak(TM) Immunosuppressants XE Kit is now CE-marked in accordance with the IVD Directive 98/79/EC, for the quantitative measurement of the immunosuppressive drugs tacrolimus (FK506;Prograf®) in liver and kidney transplant patients and everolimus (Certican®) in adult kidney and cardiac transplant patients from human whole blood samples as an aid in the...

2011-06-25 09:30:00

PRAGUE, June 25, 2011 /PRNewswire/ -- The SHARP-study has shown that lowering LDL cholesterol with ezetimibe/simvastatinleads to a significant reduction in major atherosclerotic events among CKD-patients. Whether it also has a favourable effect on renal disease progression was another of the issues addressed by the SHARP study [abstract no. 2509]. In the ezetimibe/simvastatin group, fewer patients reached the end point "end stage renal disease", but the difference was not...

2011-05-20 07:27:19

(Ivanhoe Newswire)"”Cells found naturally in the body may help prevent the rejection of an organ transplant. Research shows new cell therapy could also eliminate a transplant patient's need for life-long medication and could help their transplant last longer. Currently patients have to take immunosuppressant drugs to prevent a new organ from being rejected after transplant. Unfortunately, these drugs also suppress the immune system leaving the patient more susceptible to tumors and...

2011-05-18 16:39:05

New cell therapy to prevent organ rejection could remove the need for life-long medication and boost the longevity of a transplant for patients Researchers at King's College London have used cells found naturally in the body, to re-educate the immune system to prevent rejection of an organ transplant while remaining capable of fighting infections and cancer. Currently, patients must take immunosuppressant drugs to prevent a new organ from being rejected after transplantation. However, these...